Abstract
Introduction: Piroxicam (PRX) is a widely consumed anti-inflammatory drug, and the assays of its tablets and gels for quality control are mostly performed through High Performance Liquid Chromatography with Ultraviolet Detector (HPLC-UV).
Methods: In this regard, an alternate approach, LaFeO3 nanoparticles-modified carbon paste electrode was prepared in order to carry out PRX analysis by using voltammetric approaches.
Results: The modified electrode showed better analytical signal. The calibration curve is in the concentration range of 9.00 and 180.00 µmol·L-1 and the limit of detection was obtained as 1.00 µmol·L1 for PRX. The calculated recovery rate was fairly good (99.14%) in comparison with the declared value in the commercial product.
Conclusion: As shown by the low overall process cost, performance quickness and analytical results, the proposed method of electroanalysis with the LaFeO3 nanoparticles-modified carbon paste electrode presents a viable and interesting alternative approach to identification and determination of PRX compound in commercial products.
Keywords: LaFeO3, nanoparticles, modified carbon paste electrode, electroanalysis, voltammetry, piroxicam, oxidation.
Current Pharmaceutical Analysis
Title:Differential Pulse Voltammetric Determination of Piroxicam on Lanthanide Ferric Oxide Nanoparticles-Carbon Paste Modified Electrode
Volume: 14 Issue: 3
Author(s): Isaac Yves Lopes de Macedo, Morgana Fernandes Alecrim, Luane Ferreira Garcia, Aparecido Ribeiro de Souza, Wallans Torres Pio dos Santos, Eric de Souza Gil*, Laura M. Cubillana-Aguilera and Jose Maria Palacios-Santander*
Affiliation:
- Faculdade de Farmacia e Universidade Federal de Goias (UFG), Goiania – GO,Brazil
- Departamento de Quimica Analitica, Instituto Universitario de Investigacion en Microscopia Electronica y Materiales (IMEYMAT), Facultad de Ciencias, Universidad de Cadiz, Campus Universitario de Puerto Real, Poligono del Rio San Pedro S/N, 11510, Puerto Real, Cadiz,Spain
Keywords: LaFeO3, nanoparticles, modified carbon paste electrode, electroanalysis, voltammetry, piroxicam, oxidation.
Abstract: Introduction: Piroxicam (PRX) is a widely consumed anti-inflammatory drug, and the assays of its tablets and gels for quality control are mostly performed through High Performance Liquid Chromatography with Ultraviolet Detector (HPLC-UV).
Methods: In this regard, an alternate approach, LaFeO3 nanoparticles-modified carbon paste electrode was prepared in order to carry out PRX analysis by using voltammetric approaches.
Results: The modified electrode showed better analytical signal. The calibration curve is in the concentration range of 9.00 and 180.00 µmol·L-1 and the limit of detection was obtained as 1.00 µmol·L1 for PRX. The calculated recovery rate was fairly good (99.14%) in comparison with the declared value in the commercial product.
Conclusion: As shown by the low overall process cost, performance quickness and analytical results, the proposed method of electroanalysis with the LaFeO3 nanoparticles-modified carbon paste electrode presents a viable and interesting alternative approach to identification and determination of PRX compound in commercial products.
Export Options
About this article
Cite this article as:
Lopes de Macedo Yves Isaac , Alecrim Fernandes Morgana , Garcia Ferreira Luane , Ribeiro de Souza Aparecido, Pio dos Santos Torres Wallans , de Souza Gil Eric *, Cubillana-Aguilera M. Laura and Palacios-Santander Maria Jose*, Differential Pulse Voltammetric Determination of Piroxicam on Lanthanide Ferric Oxide Nanoparticles-Carbon Paste Modified Electrode, Current Pharmaceutical Analysis 2018; 14 (3) . https://dx.doi.org/10.2174/1573412913666170410131223
DOI https://dx.doi.org/10.2174/1573412913666170410131223 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Current Pharmaceutical Design Utility and Limitations of SP600125, an Inhibitor of Stress-Responsive c-Jun N-Terminal Kinase
Current Enzyme Inhibition Anti-Tumor Necrosis Factor Blocking Agents in the Treatment of Systemic Vasculitis
Current Immunology Reviews (Discontinued) The Role of Pericytes in Blood-Brain Barrier Function and Stroke
Current Pharmaceutical Design Strategy for Treatment of Helicobacter pylori Infection in Adults I. Updated Indications for Test and Eradication Therapy Suggested in 2000
Current Pharmaceutical Design Cytokine Transport Across the Injured Blood-Spinal Cord Barrier
Current Pharmaceutical Design Uncovering New Pharmacological Targets to Treat Neuropathic Pain by Understanding How the Organism Reacts to Nerve Injury
Current Pharmaceutical Design Novel Naproxen Derivatives: Lewis Acid/Transition-metal Free Synthesis via C-C Bond Forming Reaction
Letters in Organic Chemistry Complement 3 Receptor Expression in Individuals with Type 2 Diabetes
Recent Patents on Anti-Infective Drug Discovery Overview of SARS-CoV-2 and Possible Targets for the Management of COVID-19 Infections
Coronaviruses MicroRNAs in Diabetic β Cell Dysfunction and their Role as Biomarkers
Current Signal Transduction Therapy Serial Quantification of Urinary Protein Biomarkers to Predict Drug-induced Acute Kidney Injury
Current Drug Metabolism The Identification of Three Key Genes Related to Stemness in Thyroid Carcinoma through Comprehensive Analysis
Combinatorial Chemistry & High Throughput Screening New Immunosuppressants in Clinical Trial
Current Drug Targets - Cardiovascular & Hematological Disorders Disorders of Mechanisms of Calcium Metabolism Control as Potential Risk Factors of Prostate Cancer
Current Medicinal Chemistry Tumor Necrosis Factor-α and C-C Motif Chemokine Ligand 18 Associate with Atherosclerotic Lipid Accumulation In situ and In vitro
Current Pharmaceutical Design Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets Biomarkers and Pneumonia: Should We All be Using Them?
Current Respiratory Medicine Reviews The Complex Actions of Statins in Brain and their Relevance for Alzheimer`s Disease Treatment: An Analytical Review
Current Alzheimer Research Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment
Current HIV Research